Red cell DAMPs and inflammation
暂无分享,去创建一个
[1] M. Kaplan,et al. At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases , 2016, Journal of leukocyte biology.
[2] Yu Wang,et al. Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes. , 2016, Pharmacology & therapeutics.
[3] Shailesh Singh,et al. Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent , 2015, PloS one.
[4] R. Webb,et al. Toll-like Receptors in the Vascular System: Sensing the Dangers Within , 2016, Pharmacological Reviews.
[5] W. Barcellini,et al. Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia , 2015, Disease markers.
[6] T. Ren,et al. IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production , 2015, Journal of Translational Medicine.
[7] Jianxun Lei,et al. Hemin-Induced Mast Cell-Extracellular Traps Impart Resistance to Therapy in a Sickle Microenvironment , 2015 .
[8] R. Sluyter. P2X and P2Y receptor signaling in red blood cells , 2015, Front. Mol. Biosci..
[9] S. Reddy,et al. Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases , 2015, Current opinion in lipidology.
[10] M. Tang,et al. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy , 2015, Disease Models & Mechanisms.
[11] M. Henriques,et al. Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain , 2015, Mediators of inflammation.
[12] S. Hansson,et al. The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators , 2015, PloS one.
[13] S. Ragab,et al. Haptoglobin genotypes polymorphism as a risk factor for subclinical atherosclerosis in beta-thalassemia major children; a single center Egyptian study , 2015, Hematology.
[14] D. Covas,et al. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea. , 2015, Blood.
[15] A. Manda-Handzlik,et al. Neutrophil extracellular traps (Nets) impact upon autoimmune disorders , 2015, Central-European journal of immunology.
[16] M. Gladwin,et al. Red Blood Cells Store and Release Interleukin-33 , 2015, Journal of Investigative Medicine.
[17] P. Vicari,et al. Haptoglobin gene polymorphisms and interleukin-6 and -8 levels in patients with sickle cell anemia , 2015, Revista brasileira de hematologia e hemoterapia.
[18] A. Warnatsch,et al. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis , 2015, Science.
[19] R. Padmore. Possible mechanisms for intravenous immunoglobulin–associated hemolysis: clues obtained from review of clinical case reports , 2015, Transfusion.
[20] Haitao Guo,et al. Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.
[21] R. Locksley,et al. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. , 2015, Immunity.
[22] L. Kiger,et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease. , 2015, Blood.
[23] T. Sumpter,et al. New dog and new tricks: evolving roles for IL‐33 in type 2 immunity , 2015, Journal of leukocyte biology.
[24] K. Fitzgerald,et al. Mechanisms of inflammasome activation: recent advances and novel insights. , 2015, Trends in cell biology.
[25] Si Ming Man,et al. Regulation of inflammasome activation , 2015, Immunological reviews.
[26] A. Alayash,et al. Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease. , 2015, Blood cells, molecules & diseases.
[27] J. Simard,et al. Methemoglobin Is an Endogenous Toll-Like Receptor 4 Ligand—Relevance to Subarachnoid Hemorrhage , 2015, International journal of molecular sciences.
[28] S. Ragab,et al. Study of Serum Haptoglobin Level and its Relation to Erythropoietic Activity in Beta Thalassemia Children , 2015, Mediterranean journal of hematology and infectious diseases.
[29] Sarah L. Doyle,et al. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives , 2015, Journal of inflammation research.
[30] J. Nichols,et al. Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease , 2015, Circulation research.
[31] A. Alayash,et al. Characterization of heme binding to recombinant α1-microglobulin , 2014, Front. Physiol..
[32] E. Latz,et al. IL–1β and IL–18: inflammatory markers or mediators of hypertension? , 2014, British journal of pharmacology.
[33] I. Boldogh,et al. Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA on plasmacytoid dendritic cells. , 2014, Free radical biology & medicine.
[34] Takayuki Takahashi,et al. Heme‐related molecules induce rapid production of neutrophil extracellular traps , 2014, Transfusion.
[35] D. Pennington,et al. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.
[36] P. Buehler,et al. Haptoglobin, hemopexin, and related defense pathways—basic science, clinical perspectives, and drug development , 2014, Front. Physiol..
[37] R. Gonzalez,et al. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. , 2014, The Journal of surgical research.
[38] D. Golenbock,et al. Hemolysis-induced lethality involves inflammasome activation by heme , 2014, Proceedings of the National Academy of Sciences.
[39] G. Langsley,et al. ATP, an extracellular signaling molecule in red blood cells: A messenger for malaria? , 2014, Biomedical journal.
[40] Davide Ferrari,et al. Extracellular nucleotide and nucleoside signaling in vascular and blood disease. , 2014, Blood.
[41] W. Junger,et al. Plasma ATP is Required for Neutrophil Activation in a Mouse Sepsis Model , 2014, Shock.
[42] V. Natarajan,et al. Reactive oxygen species at the crossroads of inflammasome and inflammation , 2014, Front. Physiol..
[43] D. Wagner,et al. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. , 2014, Blood.
[44] S. Hornemann,et al. ASC has extracellular and prionoid activities that propagate inflammation , 2014, Nature Immunology.
[45] M. Idzko,et al. Nucleotide signalling during inflammation , 2014, Nature.
[46] Hailin Zhao,et al. Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. , 2014, American journal of physiology. Renal physiology.
[47] M. Bozza,et al. Heme on innate immunity and inflammation , 2014, Front. Pharmacol..
[48] J. Linden,et al. The role of adenosine signaling in sickle cell therapeutics. , 2014, Hematology/oncology clinics of North America.
[49] C. Hoppe. Inflammatory mediators of endothelial injury in sickle cell disease. , 2014, Hematology/oncology clinics of North America.
[50] J. Olson,et al. Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin. , 2014, Free radical biology & medicine.
[51] N. Conran. Intravascular Hemolysis: A Disease Mechanism Not to Be Ignored , 2014, Acta Haematologica.
[52] U. Udomsubpayakul,et al. Intravascular Hemolysis, Vascular Endothelial Cell Activation and Thrombophilia in Splenectomized Patients with Hemoglobin E/β-Thalassemia Disease , 2014, Acta Haematologica.
[53] Jiwei Yao,et al. Heme Induces IL-1β Secretion Through Activating NLRP3 in Kidney Inflammation , 2014, Cell Biochemistry and Biophysics.
[54] A. Alayash,et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. , 2014, Blood.
[55] Janet S. Lee,et al. Mechanisms of hemolysis‐associated platelet activation , 2013, Journal of thrombosis and haemostasis : JTH.
[56] O. Doumbo,et al. Haptoglobin phenotype prevalence and cytokine profiles during Plasmodium falciparum infection in Dogon and Fulani ethnic groups living in Mali , 2013, Malaria Journal.
[57] P. Buehler,et al. Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity. , 2013, Antioxidants & redox signaling.
[58] S. Ofori-Acquah,et al. Extracellular hemin crisis triggers acute chest syndrome in sickle mice. , 2013, The Journal of clinical investigation.
[59] B. Biemond,et al. Nucleosomes and neutrophil activation in sickle cell disease painful crisis , 2013, Haematologica.
[60] M. Hutchinson,et al. TLR 2 and 4 Responsiveness from Isolated Peripheral Blood Mononuclear Cells from Rats and Humans as Potential Chronic Pain Biomarkers , 2013, PloS one.
[61] J. Quigley,et al. The birth, life, and death of red blood cells: Erythropoiesis, the mature red blood cell, and cell destruction , 2013 .
[62] M. Kaste,et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. , 2013, Atherosclerosis.
[63] M. Saleh,et al. Functions of NOD-Like Receptors in Human Diseases , 2013, Front. Immunol..
[64] D. Simone,et al. Mast cell activation contributes to sickle cell pathobiology and pain in mice. , 2013, Blood.
[65] G. Núñez,et al. K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.
[66] G. Vercellotti,et al. Vasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses , 2013, ISRN oxidative medicine.
[67] P. Buehler,et al. Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies. , 2013, Cold Spring Harbor perspectives in medicine.
[68] J. Boyle,et al. Haptoglobin Genotype-Dependent Anti-Inflammatory Signaling in CD163+ Macrophages , 2013, International journal of inflammation.
[69] K. Su,et al. Neutrophil Extracellular Traps and Systemic Lupus Erythematosus. , 2013, Journal of clinical & cellular immunology.
[70] M. Yenari,et al. The immune modulating properties of the heat shock proteins after brain injury , 2013, Anatomy & cell biology.
[71] P. Buehler,et al. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. , 2013, Blood.
[72] C. Carmona-Rivera,et al. Neutrophil Extracellular Trap–Associated Protein Activation of the NLRP3 Inflammasome Is Enhanced in Lupus Macrophages , 2013, The Journal of Immunology.
[73] Samin K. Sharma,et al. Genotype-Dependent Impairment of Hemoglobin Clearance Increases Oxidative and Inflammatory Response in Human Diabetic Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[74] M. L. Ellsworth,et al. Erythrocyte‐derived ATP and Perfusion Distribution: Role of Intracellular and Intercellular Communication , 2012, Microcirculation.
[75] A. Taher,et al. β-thalassemia intermedia: a clinical perspective. , 2012, Cold Spring Harbor perspectives in medicine.
[76] M. Daemen,et al. Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis , 2012, Circulation.
[77] S. Mousa,et al. Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients With Sickle Cell Disease , 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[78] Moshe Arditi,et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.
[79] D. Golenbock,et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. , 2012, Blood.
[80] Qing-Wu Yang,et al. Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage , 2012, Journal of Neuroinflammation.
[81] J. Hartwig,et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. , 2011, Blood.
[82] P. Evans,et al. Heme Induces Heme Oxygenase 1 via Nrf2: Role in the Homeostatic Macrophage Response to Intraplaque Hemorrhage , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[83] D. Webb,et al. Cyclophilin A Is a Damage-Associated Molecular Pattern Molecule That Mediates Acetaminophen-Induced Liver Injury , 2011, The Journal of Immunology.
[84] Jie-Oh Lee,et al. Structural biology of the Toll-like receptor family. , 2011, Annual review of biochemistry.
[85] B. Biemond,et al. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management , 2011, American journal of hematology.
[86] M. Bours,et al. P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. , 2011, Frontiers in bioscience.
[87] A. Dunne. Inflammasome activation: from inflammatory disease to infection. , 2011, Biochemical Society transactions.
[88] J. Tschopp,et al. A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.
[89] C. Engwerda,et al. TNF family members and malaria: old observations, new insights and future directions. , 2010, Experimental parasitology.
[90] U. Lopes,et al. Heme Amplifies the Innate Immune Response to Microbial Molecules through Spleen Tyrosine Kinase (Syk)-dependent Reactive Oxygen Species Generation* , 2010, The Journal of Biological Chemistry.
[91] A. Chakrabarti,et al. Differential regulation of redox proteins and chaperones in HbEβ‐thalassemia erythrocyte proteome , 2010, Proteomics. Clinical applications.
[92] Z. Prohászka,et al. Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies , 2010, Cell Stress and Chaperones.
[93] Weishuang Xue,et al. Activation of TLR4-Mediated NFκB Signaling in Hemorrhagic Brain in Rats , 2010, Mediators of inflammation.
[94] W. Junger,et al. Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.
[95] F. Costa,et al. Hemoglobin disorders and endothelial cell interactions. , 2009, Clinical biochemistry.
[96] G. Vercellotti,et al. A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. , 2009, Cardiovascular & hematological disorders drug targets.
[97] R. Marée,et al. P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation , 2009 .
[98] M. Mota,et al. Cerebral malaria and the hemolysis/methemoglobin/heme hypothesis: shedding new light on an old disease. , 2009, The international journal of biochemistry & cell biology.
[99] S. Saad,et al. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy , 2009, Journal of leukocyte biology.
[100] F. Costa,et al. Newer Aspects of the Pathophysiology of Sickle Cell Disease Vaso-Occlusion , 2009, Hemoglobin.
[101] S. G. Betal,et al. Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia , 2008, Journal of thrombosis and haemostasis : JTH.
[102] S. Perrotta,et al. Hereditary spherocytosis , 2008, The Lancet.
[103] I. Quaye. Haptoglobin, inflammation and disease. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[104] M. Olsson,et al. The lipocalin α1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species , 2008, Free radical research.
[105] R. Sprague,et al. Red not dead: signaling in and from erythrocytes , 2007, Trends in Endocrinology & Metabolism.
[106] Tatiana P. Dutra,et al. Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors* , 2007, Journal of Biological Chemistry.
[107] R. Figueiredo,et al. Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.
[108] V. Fuster,et al. Downregulation of the Hemoglobin Scavenger Receptor in Individuals With Diabetes and the Hp 2-2 Genotype: Implications for the Response to Intraplaque Hemorrhage and Plaque Vulnerability , 2007, Circulation research.
[109] A. Prentice,et al. The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[110] Charles W Buffington,et al. Human plasma ATP concentration. , 2007, Clinical chemistry.
[111] V. Wahn,et al. Novel cell death program leads to neutrophil extracellular traps. , 2007, The Journal of cell biology.
[112] M. Mann,et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. , 2006, Blood.
[113] Arturo Zychlinsky,et al. An Endonuclease Allows Streptococcus pneumoniae to Escape from Neutrophil Extracellular Traps , 2006, Current Biology.
[114] Mark T Gladwin,et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. , 2005, Blood.
[115] C. Stefanadis,et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. , 2005, International journal of cardiology.
[116] K. Ahn,et al. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. , 2005, Clinical immunology.
[117] E. Dietz,et al. Short Communication: Limited influence of haptoglobin genotypes on severe malaria in Ghanaian children , 2005, Tropical medicine & international health : TM & IH.
[118] M. Gladwin,et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. , 2005, JAMA.
[119] M. Yoder,et al. Sickle cell vaso‐occlusive crisis induces the release of circulating serum heat shock protein‐70 , 2005, American journal of hematology.
[120] P. Mosci,et al. TLRs Govern Neutrophil Activity in Aspergillosis1 , 2004, The Journal of Immunology.
[121] A. Pathare,et al. Cytokine profile of sickle cell disease in Oman , 2004, American journal of hematology.
[122] R. Nagel,et al. Sickle-cell disease , 2004, The Lancet.
[123] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[124] L. Bulla,et al. The Human Erythrocyte Proteome , 2004, Molecular & Cellular Proteomics.
[125] M. Gladwin,et al. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. , 2004, Free radical biology & medicine.
[126] M. Gladwin,et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation , 2003, Nature Medicine.
[127] A. Roguin,et al. Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarction. , 2003, Diabetes care.
[128] Carl G. Figdor,et al. Different Faces of the Heme-Heme Oxygenase System in Inflammation , 2003, Pharmacological Reviews.
[129] M. Gladwin,et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. , 2002 .
[130] J. Eaton,et al. Pro-oxidant and cytotoxic effects of circulating heme. , 2002, Blood.
[131] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[132] P. Oliveira,et al. Neutrophil activation by heme: implications for inflammatory processes. , 2002, Blood.
[133] F. Altruda,et al. Hemopexin: structure, function, and regulation. , 2002, DNA and cell biology.
[134] Beverly H. Koller,et al. Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.
[135] N. Ankrah,et al. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[136] Y. Itoyama,et al. Protective effects of heme oxygenase-1 against oxidant-induced injury in the cultured human tracheal epithelium. , 1999, American journal of respiratory cell and molecular biology.
[137] K. Bourantas,et al. Acute phase proteins and interleukins in steady state sickle cell disease , 1998, European journal of haematology.
[138] H. Bang,et al. Elevated Serum Cyclophilin Levels in Patients with Severe Sepsis , 1997, Journal of Clinical Immunology.
[139] I. T. Demchenko,et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. , 1997, Science.
[140] A. Rot,et al. Presence of Cyclophilin A in Synovial Fluids of Patients with Rheumatoid Arthritis , 1997, The Journal of experimental medicine.
[141] Ann Smith,et al. Heme‐mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin , 1996, Journal of cellular physiology.
[142] J. Celis,et al. Identification of two molecular chaperons (HSX70, HSC70) in mature human erythrocytes. , 1991, Experimental cell research.
[143] W. Engel,et al. Hemopexin metabolism in patients with altered serum levels. , 1983, The Journal of laboratory and clinical medicine.
[144] U. Muller-eberhard,et al. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. , 1968, Blood.
[145] G. Kato,et al. Inflammation and sickle cell anemia , 2016 .
[146] M. Steinberg. Overview of Sickle Cell Anemia Pathophysiology , 2016 .
[147] C. Svensson,et al. Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain. , 2015, Progress in molecular biology and translational science.
[148] N. Juffermans,et al. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside. , 2015, Blood reviews.
[149] D. Pennington,et al. Cytokines and chemokines : At the crossroads of cell signalling and in fl ammatory disease , 2014 .
[150] K. Saigo,et al. Morphological and flow-cytometric analysis of haemin-induced human neutrophil activation: implications for transfusion-related acute lung injury. , 2013, Blood transfusion = Trasfusione del sangue.
[151] E. Lima,et al. Oxidative stress in sickle cell disease , 2013, Revista brasileira de hematologia e hemoterapia.
[152] J. Stockman. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids , 2012 .
[153] Yang Xia,et al. Detrimental effects of adenosine signaling in sickle cell disease , 2011, Nature Medicine.
[154] N. Beck. Anemia: General Considerations , 2009 .
[155] D. Weatherall,et al. Disorders of Hemoglobin , 2009 .
[156] M. Steinberg,et al. Disorders of Hemoglobin: Clinical and Pathophysiological Aspects of Sickle Cell Anemia , 2009 .
[157] S. Mariathasan,et al. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation , 2007, Nature Reviews Immunology.
[158] M. Gladwin,et al. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. , 2007, Blood reviews.
[159] J. Zwicker,et al. Wintrobe's Clinical Hematology , 2005 .
[160] R. Nagel,et al. Sickle-cell disease. , 2004, Lancet.
[161] Rm,et al. Sickle cell disease , 1996 .
[162] Y. Yawata. [Hemolytic anemia]. , 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.